The Princess of Wales Hospital is a district general hospital in Bridgend, Wales. It is managed by Cwm Taf Morgannwg University Health Board.

There are 200 beds in Princess of Wales Hospital.

During the past decade, Princess of Wales Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Princess of Wales Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 2 trials, followed by "NHS Greater Glasgow and Clyde" with 1 trials sponsored, "PROCEPT BioRobotics" with 1 trials sponsored, "Queen Mary University of London" with 1 trials sponsored and "Queen's Medical Center" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Princess of Wales Hospital" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator, "Breast Cancer Trials, Australia and New Zealand" with 1 trials as a collaborator and "British Heart Foundation" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Princess of Wales Hospital" are "Breast Cancer" (3 trials), "Adenocarcinoma" (1 trials), "Adenocarcinoma, Mucinous" (1 trials), "Benign Prostatic Hyperplasia (BPH)" (1 trials) and "Carcinoma" (1 trials). Many other conditions were trialed in "Princess of Wales Hospital" in a lesser frequency.

Most popular intervention types in "Princess of Wales Hospital" are "Drug" (7 trials), "Procedure" (4 trials), "Other" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "AQUABEAM System" (1 trials), "ARB + DMX-200" (1 trials), "AZD2014" (1 trials), "Adjuvant therapy" (1 trials) and "Amoxicillin-clavulanate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Princess of Wales Hospital" are 7 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Princess of Wales Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Princess of Wales Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Princess of Wales Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".